Resultados de la búsqueda

Stroeks SLVM, Henkens MTHM, Dominguez F, Merlo M, Hellebrekers DMEI, Gonzalez-Lopez E, Dal Ferro M, Ochoa JP, Venturelli F, Claes GRF, Venner MFGHM, Krapels IPC, Vanhoutte EK, van Paassen P, van den Wijngaard A, Sikking MA, van Leeuwen R, Abdul Hamid M, Li X, Brunner HG, Sinagra G, Garcia-Pavia P, Heymans SRB, Verdonschot JAJ. Genetic Landscape of Patients With Dilated Cardiomyopathy and a Systemic Immune-Mediated Disease. JACC Heart Fail (2024) S2213-1779:00617-6
Link to the full text in Repisalud
Ochoa JP, Lalaguna L, Mirelis JG, Dominguez F, Gonzalez-Lopez E, Salas C, Roustan G, McGurk KA, Zheng SL, Barton PJR, Ware JS, Gómez-Gaviro MV, Lara-Pezzi E, Garcia-Pavia P. Biallelic Loss of Function Variants in Myocardial Zonula Adherens Protein Gene (MYZAP) Cause a Severe Recessive Form of Dilated Cardiomyopathy. Circ Heart Fail (2024) 17:e011226.
Link to the full text in Repisalud
Garcia-Pavia P, Palomares JFR, Sinagra G, Barriales-Villa R, Lakdawala NK, Gottlieb RL, Goldberg RI, Elliott P, Lee P, Li H, Angeli FS, Judge DP, MacRae CA; REALM-DCM Investigators. REALM-DCM: A Phase 3, Multinational, Randomized, Placebo-Controlled Trial of ARRY-371797 in Patients With Symptomatic LMNA-Related Dilated Cardiomyopathy. Circ Heart Fail (2024) 17:e011548.
Piqueras-Flores J, Villacorta-Argüelles E, Galvin J, Climent-Payá V, Escobar-López LE, Amor-Salamanca A, Garcia-Hernandez S, Esmonde S, Martínez-Del Río J, Soto-Pérez M, Garcia-Pavia P, Ochoa JP. Intermediate-effect size p.Arg637Gln in FHOD3 increases risk of HCM and is associated with an aggressive phenotype in homozygous carriers. J MED GENET (2024) 61:423-427
García-Hernández S, de la Higuera Romero L, Ochoa JP, McKenna WJ. Emerging Themes in Genetics of Hypertrophic Cardiomyopathy: Current Status and Clinical Application. Can J Cardiol (2024) S0828-282X:00023-0.
Link to the full text in Repisalud
Remior-Pérez P, Gómez-Molina M, García-Rodríguez D, Gallego-Delgado M, Mohamed-Salem L, de Haro-Del Moral J, Hernández-Terciado F, de Castro D, Eiros-Bachiller R, Dominguez F, Gonzalez-Lopez E, Villacorta E, Pascual-Figal DA, Garcia-Pavia P. Prevalence of cardiac amyloidosis among elderly patients with recent-onset atrial fibrillation. The PREVAL-ATTR study. Can J Cardiol (2024) S0828-282X:01028-6
Link to the full text in Repisalud
Peiró-Aventín B, Cabrera-Romero E, Mora-Ayestarán N, Domínguez F, González-López E, García-Pavía P. Safety and efficacy of diflunisal in transthyretin cardiac amyloidosis. Rev Esp Cardiol (2024) 77:426-428.
Link to the full text in Repisalud
Fernández-Cisnal A, Avanzas P, Filgueiras-Rama D, Garcia-Pavia P, Sanchis L, Sanchis J. ChatGPT-4 versus human assessment in cardiology peer review. Rev Esp Cardiol (2024) S1885-5857:00066-5.
Restrepo-Córdoba MA, Chmielewski P, Truszkowska G, Peña-Peña ML, Kubánek M, Krebsová A, Lopes LR, García-Ropero Á, Merlo M, Paldino A, Peters S, Jurcut R, Barriales-Villa R, Zorio E, Hazebroek M, Mogensen J, García-Pavía P. Pregnancy in women with dilated cardiomyopathy genetic variants. Rev Esp Cardiol (2024) (24):00128-2.
Link to the full text in Repisalud
García-Pavía P, Manuel García-Pinilla J, Lozano-Bahamonde A, Yun S, García-Quintana A, Gavira-Gómez JJ, Aibar-Arregui MÁ, Barge-Caballero G, Villota JN, Bernal L, Tarilonte P. Prevalence of transthyretin cardiac amyloidosis in patients with heart failure with preserved ejection fraction: the PRACTICA study. Rev Esp Cardiol (2024) S1885-5857:00240-8.
Link to the full text in Repisalud

Páginas